These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6259610)

  • 1. [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].
    Aufrant C; Lambert-Zechovsky N; Aujard Y; Bingen E; Blum C; Beaufils F; Mathieu H
    Nouv Presse Med; 1981 Feb; 10(8):639-46. PubMed ID: 6259610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
    Goulon M; Gajdos P; Pilliot J
    Nouv Presse Med; 1981 Feb; 10(8):613-6. PubMed ID: 6259604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J; Sauvaget J
    Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
    Bastin R; Frottier J; Vilde JL; Bure A
    Nouv Presse Med; 1981 Feb; 10(8):598-600. PubMed ID: 6259601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP
    Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cefotaxime CSF levels in children with purulent meningitis (author's transl)].
    Borderon JC; Prieur D; Huguet B
    Nouv Presse Med; 1981 Feb; 10(8):580-4. PubMed ID: 6259596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cefotaxime in digestive tract infections (author's transl)].
    Paris J; Paris JC; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):647-9. PubMed ID: 6259611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
    Guy H; Chavanet P; Portier H; Kazmierczak A; Cortet P
    Nouv Presse Med; 1981 Feb; 10(8):654-6. PubMed ID: 6259613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S
    Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)].
    Motin J; Bouletreau P; Auboyer C; Bui-Xuan B; Flandrois JP; Reverdy ME
    Nouv Presse Med; 1981 Feb; 10(8):617-21. PubMed ID: 6259605
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics of cefotaxim in geriatric patients (author's transl)].
    Naber K; Adam D
    MMW Munch Med Wochenschr; 1980 Nov; 122(46):1651-4. PubMed ID: 6258061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentrations of cefotaxime in human tissues and fluids. A review of published data (author's transl)].
    Galy J; Mantel O
    Nouv Presse Med; 1981 Feb; 10(8):565-73. PubMed ID: 6259594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with cefotaxime (HR-756) in surgical patients.
    Aznar J; Muñoz E; García-Iglesias MC; Perea EJ
    Methods Find Exp Clin Pharmacol; 1981; 3(3):183-7. PubMed ID: 6265719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.